158 related articles for article (PubMed ID: 17982673)
1. The combination of glycyrrhizin and lamivudine can reverse the cisplatin resistance in hepatocellular carcinoma cells through inhibition of multidrug resistance-associated proteins.
Wakamatsu T; Nakahashi Y; Hachimine D; Seki T; Okazaki K
Int J Oncol; 2007 Dec; 31(6):1465-72. PubMed ID: 17982673
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tetramethylpyrazine on P-gp, MRP2, MRP3 and MRP5 in multidrug resistant human hepatocellular carcinoma cells.
Wang XB; Wang SS; Zhang QF; Liu M; Li HL; Liu Y; Wang JN; Zheng F; Guo LY; Xiang JZ
Oncol Rep; 2010 Jan; 23(1):211-5. PubMed ID: 19956884
[TBL] [Abstract][Full Text] [Related]
3. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
Gu W; Liu L; Fang FF; Huang F; Cheng BB; Li B
Oncol Rep; 2014 Jan; 31(1):216-22. PubMed ID: 24173654
[TBL] [Abstract][Full Text] [Related]
4. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.
Kool M; de Haas M; Scheffer GL; Scheper RJ; van Eijk MJ; Juijn JA; Baas F; Borst P
Cancer Res; 1997 Aug; 57(16):3537-47. PubMed ID: 9270026
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
[TBL] [Abstract][Full Text] [Related]
6. MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma.
Tomonari T; Takeishi S; Taniguchi T; Tanaka T; Tanaka H; Fujimoto S; Kimura T; Okamoto K; Miyamoto H; Muguruma N; Takayama T
Oncotarget; 2016 Feb; 7(6):7207-15. PubMed ID: 26769852
[TBL] [Abstract][Full Text] [Related]
7. Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma.
Nies AT; König J; Pfannschmidt M; Klar E; Hofmann WJ; Keppler D
Int J Cancer; 2001 Nov; 94(4):492-9. PubMed ID: 11745434
[TBL] [Abstract][Full Text] [Related]
8. Association between reversal of multidrug resistance by methyl jasmonate and P-glycoprotein ATPase activity in hepatocellular carcinoma.
Wang CF; Wang YQ; Huang FZ; Nie WP; Liu XY; Jiang XZ
J Int Med Res; 2013 Aug; 41(4):964-74. PubMed ID: 23867448
[TBL] [Abstract][Full Text] [Related]
9. Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU.
Shi LX; Ma R; Lu R; Xu Q; Zhu ZF; Wang L; Zhou CL; Li XL; Zhang HL; Yao Z
Cancer Lett; 2008 Sep; 269(1):101-10. PubMed ID: 18538471
[TBL] [Abstract][Full Text] [Related]
10. Expression of multidrug resistance-associated protein 2 is involved in chemotherapy resistance in human pancreatic cancer.
Noma B; Sasaki T; Fujimoto Y; Serikawa M; Kobayashi K; Inoue M; Itsuki H; Kamigaki M; Minami T; Chayama K
Int J Oncol; 2008 Dec; 33(6):1187-94. PubMed ID: 19020751
[TBL] [Abstract][Full Text] [Related]
11. [Methylated oligonucleotide inhibiting expression of human MRP2 and reversing multidrug resistance in hepatocellular carcinoma Cell HepG2].
Li WH; Cui Y; Zhu JR
Ai Zheng; 2004 Aug; 23(8):900-4. PubMed ID: 15301711
[TBL] [Abstract][Full Text] [Related]
12. Characterization and resistance mechanisms of cisplatin-resistant human hepatocellular carcinoma cell line.
Yang JX; Luo Y; Qiu HM; Tang WX
Saudi Med J; 2009 Jan; 30(1):35-40. PubMed ID: 19139770
[TBL] [Abstract][Full Text] [Related]
13. Steroidal saponin of Trillium tschonoskii. Reverses multidrug resistance of hepatocellular carcinoma.
Wang H; Zhai Z; Li N; Jin H; Chen J; Yuan S; Wang L; Zhang J; Li Y; Yun J; Fan J; Yi J; Ling R
Phytomedicine; 2013 Aug; 20(11):985-91. PubMed ID: 23786867
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of sirtuins 1 and 2 impairs cell survival and migration and modulates the expression of P-glycoprotein and MRP3 in hepatocellular carcinoma cell lines.
Ceballos MP; Decándido G; Quiroga AD; Comanzo CG; Livore VI; Lorenzetti F; Lambertucci F; Chazarreta-Cifre L; Banchio C; Alvarez ML; Mottino AD; Carrillo MC
Toxicol Lett; 2018 Jun; 289():63-74. PubMed ID: 29545174
[TBL] [Abstract][Full Text] [Related]
15. Changes in the Expression of Various Transporters as Influencing Factors of Resistance to Cisplatin.
Kishimoto S; Yasuda M; Fukushima S
Anticancer Res; 2017 Oct; 37(10):5477-5484. PubMed ID: 28982859
[TBL] [Abstract][Full Text] [Related]
16. [Detection of multidrug resistance-associated proteins MRP2, MRP3, and MRP5 mRNA expressions in hepatocarcinoma cells using SYBR real-time PCR].
Zhang L; Fang CH; Fan YF
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):219-21. PubMed ID: 18250047
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of P-glycoprotein 1 (Pgp1, ABCB1)-mediated doxorubicin-resistant PLHC-1 hepatoma fish cell line.
Zaja R; Caminada D; Loncar J; Fent K; Smital T
Toxicol Appl Pharmacol; 2008 Mar; 227(2):207-18. PubMed ID: 18076962
[TBL] [Abstract][Full Text] [Related]
18. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
Lu F; Hou YQ; Song Y; Yuan ZJ
Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179
[TBL] [Abstract][Full Text] [Related]
19. Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma.
Kataoka J; Shiraha H; Horiguchi S; Sawahara H; Uchida D; Nagahara T; Iwamuro M; Morimoto H; Takeuchi Y; Kuwaki K; Onishi H; Nakamura S; Takaki A; Nouso K; Yagi T; Yamamoto K; Okada H
Oncol Rep; 2016 May; 35(5):2576-82. PubMed ID: 26985715
[TBL] [Abstract][Full Text] [Related]
20. Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.
Calatozzolo C; Gelati M; Ciusani E; Sciacca FL; Pollo B; Cajola L; Marras C; Silvani A; Vitellaro-Zuccarello L; Croci D; Boiardi A; Salmaggi A
J Neurooncol; 2005 Sep; 74(2):113-21. PubMed ID: 16193381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
